Cyril Amarchand Mangaldas has advised Blackstone on its 75-billion-rupee ($1 billion) acquisition of Piramal Group’s Piramal Glass, which was counselled by Trilegal.

According to media reports, Blackstone’s acquisition would be Piramal's second recent deal with a major private equity firm, coming after a June agreement to sell a 20 percent stake in its Piramal Pharma unit to The Carlyle Group.

The Cyril Amarchand Mangaldas team was led by partner Shishir Vayttaden. Meanwhile, partners Sridhar Gorthi and Harsh Maggon led the Trilegal team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com

Related Articles

Weil, Wong & Partners guide $2.6 bln Malaysia airport deal

by Nimitt Dixit |

U.S law firm Weil, Gotshal & Manges and Wong & Partners, Baker McKenzie’s Malaysia member firm, have guided investment firm Global Infrastructure Partners (GIP) and a consortium led by Khazanah Nasional Bhd, respectively, on a $2.6 billion take-private offer for Malaysia Airports Holdings (MAH).

Nishimura continues SEA growth with energy partner

by Nimitt Dixit |

Japanese Big Six law firm Nishimura & Asahi has continued the planned expansion of its Southeast Asia offerings with the addition of energy-focused finance and M&A partner Sean Conaty.

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.